Diazotrifluoropropionamido-containing prenylcysteines: Syntheses and applications for studying isoprenoid-protein interactions

Organic Letters

Volumn 5, Issue 5, 2003, Pages 609-612

  Kale, Tamara A ^a   Distefano, Mark D ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE DERIVATIVE; ISOPRENOID; PROPIONAMIDE DERIVATIVE; PROTEIN; RHODIUM DERIVATIVE; AMIDE; BENZOPHENONE; BENZOPHENONE DERIVATIVE; BIOTIN; CROSS LINKING REAGENT; CYSTEINE; DIAZONIUM COMPOUND; DIAZOTRIFLUOROPROPIONAMIDE; DRUG DERIVATIVE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; STREPTAVIDIN;

ARTICLE; AUTORADIOGRAPHY; DRUG BINDING SITE; DRUG PROTEIN BINDING; NUCLEAR MAGNETIC RESONANCE; PHOTOAFFINITY LABELING; PHOTOLYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRENYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; BINDING COMPETITION; BINDING SITE; CHEMISTRY; METABOLISM; PROTEIN PROCESSING; SYNTHESIS;

AMIDES; AUTORADIOGRAPHY; BENZOPHENONES; BINDING SITES; BINDING, COMPETITIVE; BIOTIN; CROSS-LINKING REAGENTS; CYSTEINE; DIAZONIUM COMPOUNDS; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; PHOTOAFFINITY LABELS; PHOTOLYSIS; PROTEIN ISOPRENYLATION; STREPTAVIDIN;

EID: 0037866872     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol026752a     Document Type: Article

References (38)

1. Sebti, S. M.; Hamilton, A. D. Oncogene 2000, 19, 6584-6593.
2. Cox, A. D.; Der, C. J. Curr. Opin. Cell. Biol. 1992, 4, 1008-1016.
3. Marshall, C. J. Science 1993, 259, 1865-1866.
4. Zhang, F. L.; Casey, P. J. Annu. Rev. Biochem. 1996, 65, 241-269.
5. Geyer, M.; Wittinghofer, A. Curr. Opin. Struct. Biol. 1997, 7, 786-792.
6. Marecak, D. M.; Horiuchi, Y.; Arai, H.; Shimonaga, M.; Maki, Y.; Koyama, T.; Ogura, K.; Prestwich, G. D. Bioorg. Med. Chem. Lett. 1997, 7, 1973-1978.
7. Yokoyama, K.; McGeady, P.; Gelb, M. H. Biochemistry 1995, 34, 1344-1354.
8. Omer, C. A.; Kral, A. M.; Diehl, R. E.; Prendergast, G. C.; Powers, S.; Allen, C. M.; Gibbs, J. B.; Kohl, N. E. Biochemistry 1993, 32, 5167-5176.
9. Turek, T. C.; Gaon, I.; Distefano, M. D.; Strickland, C. L. J. Org. Chem. 2001, 66, 3253-3264.
10. Turek, T. C.; Gaon, I.; Gamache, D.; Distefano, M. D. Bioorg. Med. Chem. Lett. 1997, 7, 2125-2130.
11. Gaon, I.; Turek, T. C.; Distefano, M. D. Tetrahedron Lett. 1996, 37, 8833-8836.
12. Edelstein, R. L. Ph.D. Thesis, University of Minnesota, Minneapolis, Minnesota, 1997.
13. Edelstein, R. L.; Distefano, M. D. Biochem. Biophys. Res. Commun. 1997, 235, 377-382.
14. Kale, T. A.; Raab, C.; Yu, N.; Dean, D. C.; Distefano, M. D. J. Am. Chem. Soc. 2001, 123, 4373-4381.
15. Kale, T. A.; Raab, C.; Yu, N.; Aquino, E.; Dean, D. C. J. Labelled Compds. Radiopharm. 2003, 46, 29-54.
16. Kale, T. A.; Turek, T. C.; Chang, V.; Gautam, N.; Distefano, M. D. Methods Enzymol. 2002, 344, 245-258.
17. Dormán, G.; Prestwich, G. D. Biochemistry 1994, 33, 5661-5673.
18. Quellhorst, G. J., Jr.; Allen, C. M.; Wessling-Resnick, M. J. Biol. Chem. 2001, 276, 40727-40733.
19. Mondal, M. S.; Wang, Z.; Seeds, A. M.; Rando, R. R. Biochemistry 2000, 39, 406-412.
20. 1H NMR.
21. Both cysteine methyl esters and their free acid counterparts are desirable prenylcysteine analogues, as not all proteins are methylesterified.
22. Thompson, A. S.; Humphrey, G. R.; DeMarco, A. M.; Mathre, D. J.; Grabowski, E. J. J. J. Org. Chem. 1993, 58, 5886-5888.
23. Murahashi, S.-I.; Taniguchi, Y.; Imada, Y.; Tanigawa, Y. J. Org. Chem. 1989, 54, 3292-3303.
24. Compound 6b and subsequent products therefrom are, in reality, each mixtures of two diastereomers due to the chirality at C-6.
25. Viaud, M. C.; Rollin, P. Synthesis 1990, 130-133.
26. Safi, M.; Fahrang, R.; Sinou, D. Tetrahedron Lett. 1990, 31, 527-530.
27. Trost, B. M.; Pulley, S. R. Tetrahedron Lett. 1995, 36, 8737-8740.
28. Gagneux, A.; Winstein, S.; Young, W. G. J. Am. Chem. Soc. 1969, 82, 5956-5957.
29. Xue, C.-B.; Becker, J. M.; Naider, F. Tetrahedron Lett. 1992, 33, 1435-1438.
30. Bernard, M.; Ford, W. T. J. Org. Chem. 1983, 48, 326-332.
31. Hahn, K. M.; Hastie, S. B.; Sundberg, R. J. Photochem. Photobiol. 1992, 55, 17-27.
32. Theodore, L. J.; Nelson, W. L.; Dave, B.; Giacomini, J. C. J. Med. Chem. 1990, 33, 873-877.
33. Willchek, M., Bayer, E. A., Eds. Avidin-Biotin Technology; Academic Press: San Diego, 1990; Vol. 184.
34. Biotinylated prenylated peptides have been prepared via solid-phase synthesis, where biotin-avidin chemistry was utilized in subsequent enzymatic assays (Dolence, E. K.; Dolence, J. M.; Poulter, C. D. Bioconjugate Chem. 2001, 12, 35-43. Liu, L.; Jang, G.-F.; Farnsworth, C.; Yokoyama, K.; Glomset, J. A.; Gelb, M. H. Methods Enzymol. 1995, 250, 189-206).
35. Biotinylated prenylated peptides have been prepared via solid-phase synthesis, where biotin-avidin chemistry was utilized in subsequent enzymatic assays (Dolence, E. K.; Dolence, J. M.; Poulter, C. D. Bioconjugate Chem. 2001, 12, 35-43. Liu, L.; Jang, G.-F.; Farnsworth, C.; Yokoyama, K.; Glomset, J. A.; Gelb, M. H. Methods Enzymol. 1995, 250, 189-206).
36. Yang, C.-C.; Marlowe, C. K.; Kania, R. J. Am. Chem. Soc. 1991, 113, 3177-3178.
37. It should be noted that instead of biotinylation of the amine-containing prenylcysteine compound 12 in Scheme 2, attempts were made to synthesize N-biotinylated cysteine methyl ester and then alkylate its free thiol with bromide 8. This method did not give reproducible results. The potential for oxidation of the cysteinyl sulfhydryl group as well as disulfide formation complicated this reaction. The method shown in Scheme 2 is considerably more reliable.
38. Hoffman, G. R.; Nassar, N.; Cerione, R. A. Cell 2000, 100, 345-356.